Loading
Latest filing published 23 Jan 2023 for Aptose Biosciences Inc.. Read the official filing
No signal scores available.
Only one filing by Philippe Ledru is known so far (23 January 2023): a share grant, in Aptose Biosciences Inc. That is too little to draw conclusions. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration